Ostomy and wound care products.
Coloplast — the Humlebæk-based Danish medical-device group (Copenhagen Nasdaq-listed) — is a long-standing supplier to the Portuguese health system in ostomy care, continence care, wound and skin care, and interventional urology. The company reaches Portuguese patients through hospital tenders, community pharmacies and SNS (Serviço Nacional de Saúde) reimbursement schemes, with clinical education programmes for nurses specialising in stoma and continence care.
As with its broader southern-European footprint, Coloplast's Portuguese activity sits inside the group's Iberia organisation, and its consumer-healthcare products are distributed via the main Portuguese pharmaceutical wholesalers and hospital group purchasing channels.
Coloplast is one of several Danish medtech leaders (alongside Novo Nordisk, Demant and others) that have built sustained Portuguese patient bases through SNS tenders and pharmacy distribution. Their combined presence is a quiet but material pillar of the Denmark → Portugal healthcare corridor, and a reference point for other Nordic medtech companies scoping Iberian entry.
Fractio helps Nordic companies enter the Portuguese market — from market sizing to first sales, hiring, and legal setup.
Talk to Fractio →